Hyperthermia: an effective strategy to induce apoptosis in cancer cells
/in Hyperthermia, International PublicationsOncolysis by paramyxoviruses: preclinical and clinical studies
/in International Publications, Newcastle Disease VirusDendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
/in Dendritic Cells, International PublicationsImproving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
/in Dendritic Cells, Hyperthermia, International PublicationsValidity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients
/in Colorectal Cancer, International PublicationsOncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusDendritic Cells as Pharmacological Tools for Cancer Immunotherapy
/in Dendritic Cells, International PublicationsLenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
/in Dendritic Cells, International Publications, Multiple MyelomaNatural and therapy-induced immunosurveillance in breast cancer
/in Breast Cancer, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer